PRELUDE CAPITAL MANAGEMENT, LLC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2021$202,000
-65.7%
1,386
-53.9%
0.01%
-72.2%
Q2 2021$589,000
+37.6%
3,008
+27.1%
0.02%
+63.6%
Q1 2021$428,000
+12.6%
2,366
-11.8%
0.01%
+10.0%
Q4 2020$380,000
+39.2%
2,683
+22.6%
0.01%
-23.1%
Q3 2020$273,000
+221.2%
2,189
+130.4%
0.01%
+160.0%
Q2 2020$85,0009500.01%
Other shareholders
10X GENOMICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Venrock Management VI, LLC 8,185,565$952,538,00099.56%
Foresite Capital Management I, LLC 2,750,000$342,870,00096.54%
Foresite Capital Management II, LLC 3,503,528$436,820,00095.05%
12 West Capital Management LP 1,922,000$239,635,00011.66%
FINANCIAL CONSULATE, INC 163,366$20,368,0009.67%
JS Capital Management LLC 606,400$75,606,0003.91%
Asymmetry Capital Management, L.P. 43,512$5,425,0003.49%
Pinz Capital Management, LP 55,400$6,907,0002.52%
HAMILTON LANE ADVISORS LLC 37,087$4,624,0002.24%
RTW INVESTMENTS, LP 660,933$82,405,0001.98%
View complete list of 10X GENOMICS INC shareholders